Advertisement

Atypical and Malignant Meningioma: Outcome and Prognostic Factors in 119 Irradiated Patients. A Multicenter, Retrospective Study of the Rare Cancer Network

Published:February 22, 2008DOI:https://doi.org/10.1016/j.ijrobp.2007.12.020

      Purpose

      To retrospectively analyze and assess the outcomes and prognostic factors in a large number of patients with atypical and malignant meningiomas.

      Methods and Materials

      Ten academic medical centers participating in this Rare Cancer Network contributed 119 cases of patients with atypical or malignant meningiomas treated with external beam radiotherapy (EBRT) after surgery or for recurrence. Eligibility criteria were histologically proven atypical or anaplastic (malignant) meningioma (World Health Organization Grade 2 and 3) treated with fractionated EBRT after initial resection or for recurrence, and age >18 years. Sex ratio (male/female) was 1.3, and mean (±SD) age was 57.6 ± 12 years. Surgery was macroscopically complete (Simpson Grades 1–3) in 71% of patients; histology was atypical and malignant in 69% and 31%, respectively. Mean dose of EBRT was 54.6 ± 5.1 Gy (range, 40–66 Gy). Median follow-up was 4.1 years.

      Results

      The 5- and 10-year actuarial overall survival rates were 65% and 51%, respectively, and were significantly influenced by age >60 years (p = 0.005), Karnofsky performance status (KPS) (p = 0.01), and high mitotic rate (p = 0.047) on univariate analysis. On multivariate analysis age >60 years (p = 0.001) and high mitotic rate (p = 0.02) remained significant adverse prognostic factors. The 5- and 10-year disease-free survival rates were 58% and 48%, respectively, and were significantly influenced by KPS (p = 0.04) and high mitotic rate (p = 0.003) on univariate analysis. On multivariate analysis only high mitotic rate (p = 0.003) remained a significant prognostic factor.

      Conclusions

      In this multicenter retrospective study, age, KPS, and mitotic rate influenced outcome. Multicenter prospective studies are necessary to clarify the management and prognostic factors of such a rare disease.
      To read this article in full you will need to make a payment
      ASTRO Member Login
      ASTRO Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features.
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Jääskelainen J.
        • Haltia M.
        • Servo A.
        Atypical and anaplastic meningiomas: Radiology, surgery, radiotherapy and outcome.
        Surg Neurol. 1986; 25: 233-242
        • Goyal L.
        • Suh J.
        • Mohan D.
        • et al.
        Local control and overall survival in atypical meningioma: A retrospective study.
        Int J Radiat Oncol Biol Phys. 2000; 46: 57-61
        • Pourel N.
        • Auque J.
        • Bracard S.
        • et al.
        Efficacy of external fractionated radiation therapy in the treatment of meningiomas: A 20-year experience.
        Radiat Oncol. 2001; 61: 65-70
      1. Kleihues P. Cavenee W. World Health Organization classification of tumors: Pathology and genetics of tumors of the nervous system. IARC Press, Lyon, France2000
        • Mahmood A.
        • Caccamo D.
        • Tomecek F.
        • et al.
        Atypical and malignant meningiomas: A clinicopathological review.
        Neurosurgery. 1993; 33: 955-963
        • Modha A.
        • Gutin P.
        Diagnosis and treatment of atypical and anaplastic meningiomas: A review.
        Neurosurgery. 2005; 57: 538-550
        • Perry A.
        • Scheithauer B.W.
        • Stafford S.L.
        • et al.
        “Malignancy” in meningiomas: A clinicopathologic study of 116 patients, with grading implications.
        Cancer. 1999; 85: 2046-2056
        • Milosevic M.F.
        • Frost P.J.
        • Lapierre N.J.
        • et al.
        Radiotherapy for atypical or malignant intracranial meningioma.
        Int J Radiat Oncol Biol Phys. 1996; 34: 817-822
        • Palma L.
        • Celli P.
        • Franco C.
        • et al.
        Long-term prognosis for atypical and malignant meningiomas: A study of 71 surgical cases.
        J Neurosurg. 1997; 86: 793-800
        • Jääskelainen J.
        Seemingly complete removal of histologically benign intracranial meningioma: Late recurrence rate and factors predicting recurrence in 657 patients. A multivariate analysis.
        Surg Neurol. 1986; 26: 461-469
        • Perry A.
        • Stafford S.L.
        • Scheithauer B.W.
        • et al.
        Meningioma grading: An analysis of histologic parameters.
        Am J Surg Pathol. 1997; 21: 1455-1465
        • Whittle I.
        • Smith C.
        • Navoo P.
        • et al.
        Meningiomas.
        Lancet. 2004; 363: 1535-1543
        • Ming-Tak Ho D.
        • Hsu C.
        • Ting L.
        • et al.
        Histopathology and MIB-1 labeling index predicted recurrence of meningiomas. A proposal of diagnostic criteria for patients with atypical meningioma.
        Cancer. 2002; 94: 1538-1547
        • Weber R.
        • Bostrom J.
        • Wolter M.
        • et al.
        Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression.
        Proc Natl Acad Sci U S A. 1997; 94: 14719-14724
        • Murakami M.
        • Hashimoto N.
        • Takahashi Y.
        • et al.
        A consistent region of deletion on 1p36 in meningiomas: Identification and relation to malignant progression.
        Cancer Genet Cytogenet. 2003; 140: 99-106
        • Perry A.
        • Banerjee R.
        • Lohse C.
        • et al.
        A role for chromosome 9p21 deletions in the malignant progression of meningiomas and the prognosis of anaplastic meningiomas.
        Brain Pathol. 2002; 12: 183-190
        • Mirimanoff R.O.
        New radiotherapy technologies for meningiomas: 3D conformal radiotherapy? Radiosurgery? Stereotactic radiotherapy? Intensity-modulated radiotherapy? Proton beam radiotherapy? Spot scanning proton radiation therapy… or nothing at all?.
        Radiother Oncol. 2004; 71: 247-249
        • Goldsmith B.J.
        • Wara W.M.
        • Wilson C.B.
        • et al.
        Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990.
        J Neurosurg. 1994; 80: 195-201

      Comments

      Commenting Guidelines

      To submit a comment for a journal article, please use the space above and note the following:

      • We will review submitted comments as soon as possible, striving for within two business days.
      • This forum is intended for constructive dialogue. Comments that are commercial or promotional in nature, pertain to specific medical cases, are not relevant to the article for which they have been submitted, or are otherwise inappropriate will not be posted.
      • We require that commenters identify themselves with names and affiliations.
      • Comments must be in compliance with our Terms & Conditions.
      • Comments are not peer-reviewed.